Reddoch James F.
EVP & Chief Scientific Officer at RPRX
- Sold, on record
- $39.2M
- Dollars the filings state
- Form 4 sales
- 14
- Latest Sep 28, 2022
- Form 144 notices
- 0
- Proposed sales
- Companies
- 1
- Filed as an executive or holder
Companies
- RPRXRoyalty Pharma plcEVP & Chief Scientific Officer
Sales by reason
Form 4 sales per month, last 12 months.
Timeline
- 1 Form 4 sale RPRXPlan not statedJul 8, 2021 2021
Sold 73,117 shares at $42.19 ($3.1M)
Reddoch James F., EVP, Research & Investments
Sold 5.8% of holdings ($53.6M position)1.2M shares left1.4x usual sizeFiling
- 2 Form 4 sale RPRXPlan not statedJul 14, 2021 +6 days
Sold 17,934 shares at $42.01 ($753k)
Reddoch James F., EVP, Research & Investments
Sold 1.5% of holdings ($50.3M position)1.2M shares left0.3x usual sizeFiling
- 3 Form 4 sale RPRXPlan not statedJul 26, 2021 +12 days
Sold 8,949 shares at $39.78 ($356k)
Reddoch James F., EVP, Research & Investments
Sold 0.8% of holdings ($46.9M position)1.2M shares left0.2x usual sizeFiling
- 4 Form 4 sale RPRXPlan not statedJul 26, 2021 same day
Sold 8,949 shares at $39.78 ($356k)
Reddoch James F., EVP, Research & Investments
Sold 0.8% of holdings ($46.9M position)1.2M shares left0.2x usual sizeFiling
- 5 Form 4 sale RPRXPlan not statedMay 19, 2022 +297 days
Sold 75,000 shares at $40.44 ($3M)
Reddoch James F., EVP & Chief Scientific Officer
Sold 6.4% of holdings ($47.3M position)1.1M shares left1.6x usual sizeFiling
- 6 Form 4 sale RPRXPlan not statedMay 27, 2022 +8 days
Sold 75,000 shares at $41.08 ($3.1M)
Reddoch James F., EVP & Chief Scientific Officer
Sold 6.8% of holdings ($45M position)1M shares left1.5x usual sizeFiling
- 7 Form 4 sale RPRXPlan not statedJun 8, 2022 +12 days
Sold 100,000 shares at $41.56 ($4.2M)
Reddoch James F., EVP & Chief Scientific Officer
Sold 9.8% of holdings ($42.4M position)920,800 shares left1.9x usual sizeFiling
- 8 Form 4 sale RPRXPlan not statedSep 28, 2022 +112 days
Sold 100,000 shares at $41.23 ($4.1M)
Reddoch James F., EVP & Chief Scientific Officer
Sold 10.9% of holdings ($38M position)820,800 shares left1.8x usual sizeFiling
Every transaction
Loading transactions…
Sales and notices (14)
| Source | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Sep 28, 2022 | Sep 30, 2022 | RPRX | EVP & Chief Scientific Officer | Form 4 sale | 100,000 | $4.1M | 10.9% | Plan not stated | SEC |
| Jun 8, 2022 | Jun 10, 2022 | RPRX | EVP & Chief Scientific Officer | Form 4 sale | 100,000 | $4.2M | 9.8% | Plan not stated | SEC |
| May 27, 2022 | May 31, 2022 | RPRX | EVP & Chief Scientific Officer | Form 4 sale | 75,000 | $3.1M | 6.8% | Plan not stated | SEC |
| May 19, 2022 | May 23, 2022 | RPRX | EVP & Chief Scientific Officer | Form 4 sale | 75,000 | $3M | 6.4% | Plan not stated | SEC |
| Jul 26, 2021 | Jul 27, 2021 | RPRX | EVP, Research & Investments | Form 4 sale | 8,949 | $356k | 0.8% | Plan not stated | SEC |
| Jul 26, 2021 | Jul 27, 2021 | RPRX | EVP, Research & Investments | Form 4 sale | 8,949 | $356k | 0.8% | Plan not stated | SEC |
| Jul 14, 2021 | Jul 14, 2021 | RPRX | EVP, Research & Investments | Form 4 sale | 17,934 | $753k | 1.5% | Plan not stated | SEC |
| Jul 8, 2021 | Jul 8, 2021 | RPRX | EVP, Research & Investments | Form 4 sale | 73,117 | $3.1M | 5.8% | Plan not stated | SEC |
| Jun 8, 2021 | Jun 8, 2021 | RPRX | EVP, Research & Investments | Form 4 sale | 200,000 | $9.1M | 13.6% | Unusual | SEC |
| Jun 2, 2021 | Jun 4, 2021 | RPRX | EVP, Research & Investments | Form 4 sale | 50,000 | $2.1M | 3.3% | Plan not stated | SEC |
| Apr 14, 2021 | Apr 16, 2021 | RPRX | EVP, Research & Investments | Form 4 sale | 55,714 | $2.3M | 21.8% | Plan not stated | SEC |
| Apr 12, 2021 | Apr 14, 2021 | RPRX | EVP, Research & Investments | Form 4 sale | 359 | $15k | 0.1% | Plan not stated | SEC |
| Mar 22, 2021 | Mar 24, 2021 | RPRX | EVP, Research & Investments | Form 4 sale | 43,927 | $2M | 14.6% | Plan not stated | SEC |
| Mar 2, 2021 | Mar 4, 2021 | RPRX | EVP, Research & Investments | Form 4 sale | 100,000 | $4.7M | 25.0% | Unusual | SEC |